Related Research Articles
Metabolic syndrome is a clustering of at least three of the following five medical conditions: abdominal obesity, high blood pressure, high blood sugar, high serum triglycerides, and low serum high-density lipoprotein (HDL).
Type 2 diabetes (T2D), formerly known as adult-onset diabetes, is a form of diabetes mellitus that is characterized by high blood sugar, insulin resistance, and relative lack of insulin. Common symptoms include increased thirst, frequent urination, fatigue and unexplained weight loss. Symptoms may also include increased hunger, having a sensation of pins and needles, and sores (wounds) that do not heal. Often symptoms develop slowly. Long-term complications from high blood sugar include heart disease, stroke, diabetic retinopathy, which can result in blindness, kidney failure, and poor blood flow in the lower-limbs, which may lead to amputations. The sudden onset of hyperosmolar hyperglycemic state may occur; however, ketoacidosis is uncommon.
The Mediterranean diet is a concept first invented in 1975 by the American biologist Ancel Keys and chemist Margaret Keys. The diet took inspiration from the supposed eating habits and traditional food typical of southern Spain, southern Italy, and Crete, and formulated in the early 1960s. It is distinct from Mediterranean cuisine, which covers the actual cuisines of the Mediterranean countries, and from the Atlantic diet of northwestern Spain and Portugal. While inspired by a specific time and place, the "Mediterranean diet" was later refined based on the results of multiple scientific studies.
Glycated hemoglobin, glycohemoglobin, glycosylated hemoglobin is a form of hemoglobin (Hb) that is chemically linked to a sugar. Several types of glycated hemoglobin measures exist, of which HbA1c, or simply A1c, is a standard single test. Most monosaccharides, including glucose, galactose, and fructose, spontaneously bond with hemoglobin when present in the bloodstream. However, glucose is only 21% as likely to do so as galactose and 13% as likely to do so as fructose, which may explain why glucose is used as the primary metabolic fuel in humans.
The term diabetes includes several different metabolic disorders that all, if left untreated, result in abnormally high concentrations of a sugar called glucose in the blood. Diabetes mellitus type 1 results when the pancreas no longer produces significant amounts of the hormone insulin, usually owing to the autoimmune destruction of the insulin-producing beta cells of the pancreas. Diabetes mellitus type 2, in contrast, is now thought to result from autoimmune attacks on the pancreas and/or insulin resistance. The pancreas of a person with type 2 diabetes may be producing normal or even abnormally large amounts of insulin. Other forms of diabetes mellitus, such as the various forms of maturity-onset diabetes of the young, may represent some combination of insufficient insulin production and insulin resistance. Some degree of insulin resistance may also be present in a person with type 1 diabetes.
Gerald M. "Jerry" Reaven was an American endocrinologist and professor emeritus in medicine at the Stanford University School of Medicine in Stanford, California, United States.
A diabetic diet is a diet that is used by people with diabetes mellitus or high blood sugar to minimize symptoms and dangerous complications of long-term elevations in blood sugar.
Prediabetes is a component of metabolic syndrome and is characterized by elevated blood sugar levels that fall below the threshold to diagnose diabetes mellitus. It usually does not cause symptoms but people with prediabetes often have obesity, dyslipidemia with high triglycerides and/or low HDL cholesterol, and hypertension. It is also associated with increased risk for cardiovascular disease (CVD). Prediabetes is more accurately considered an early stage of diabetes as health complications associated with type 2 diabetes often occur before the diagnosis of diabetes.
Complications of diabetes are secondary diseases that are a result of elevated blood glucose levels that occur in diabetic patients. These complications can be divided into two types: acute and chronic. Acute complications are complications that develop rapidly and can be exemplified as diabetic ketoacidosis (DKA), hyperglycemic hyperosmolar state (HHS), lactic acidosis (LA), and hypoglycemia. Chronic complications develop over time and are generally classified in two categories: microvascular and macrovascular. Microvascular complications include neuropathy, nephropathy, and retinopathy; while cardiovascular disease, stroke, and peripheral vascular disease are included in the macrovascular complications.
Empagliflozin, sold under the brand name Jardiance, among others, is an antidiabetic medication used to improve glucose control in people with type 2 diabetes. It is taken by mouth.
Globally, an estimated 537 million adults are living with diabetes, according to 2019 data from the International Diabetes Federation. Diabetes was the 9th-leading cause of mortality globally in 2020, attributing to over 2 million deaths annually due to diabetes directly, and to kidney disease due to diabetes. The primary causes of type 2 diabetes is diet and physical activity, which can contribute to increased BMI, poor nutrition, hypertension, alcohol use and smoking, while genetics is also a factor. Diabetes prevalence is increasing rapidly; previous 2019 estimates put the number at 463 million people living with diabetes, with the distributions being equal between both sexes icidence peaking around age 55 years old. The number is projected to 643 million by 2030, or 7079 individuals per 100,000, with all regions around the world continue to rise. Type 2 diabetes makes up about 85-90% of all cases. Increases in the overall diabetes prevalence rates largely reflect an increase in risk factors for type 2, notably greater longevity and being overweight or obese. The prevalence of African Americans with diabetes is estimated to triple by 2050, while the prevalence of whites is estimated to double. The overall prevalence increases with age, with the largest increase in people over 65 years of age. The prevalence of diabetes in America is estimated to increase to 48.3 million by 2050.
Diabetes mellitus, often known simply as diabetes, is a group of common endocrine diseases characterized by sustained high blood sugar levels. Diabetes is due to either the pancreas not producing enough insulin, or the cells of the body becoming unresponsive to the hormone's effects. Classic symptoms include thirst, polyuria, weight loss, and blurred vision. If left untreated, the disease can lead to various health complications, including disorders of the cardiovascular system, eye, kidney, and nerves. Diabetes accounts for approximately 4.2 million deaths every year, with an estimated 1.5 million caused by either untreated or poorly treated diabetes.
Dulaglutide, sold under the brand name Trulicity among others, is a medication used for the treatment of type 2 diabetes in combination with diet and exercise. It is also approved in the United States for the reduction of major adverse cardiovascular events in adults with type 2 diabetes who have established cardiovascular disease or multiple cardiovascular risk factors. It is a once-weekly injection.
Frank B. Hu is a Chinese American nutrition and diabetes researcher. He is Chair of the Department of Nutrition and the Fredrick J. Stare Professor of Nutrition and Epidemiology at the Harvard T.H. Chan School of Public Health, and Professor of Medicine at the Harvard Medical School.
Sleep epidemiology is an emerging branch of the discipline of epidemiology. It is a growing field of scientific enquiry, with the first documented modern epidemiological survey being conducted in 1979.
Elizabeth Louise Barrett-Connor was Chief of the Division of Epidemiology and Distinguished Professor at the University of California, San Diego. She investigated the role of hormones in pathogenesis of cardiovascular disease, diabetes and osteoporosis.
Harry Keen CBE was an English diabetologist and a professor of human metabolism at Guy's Hospital. He was the first to identify microalbuminuria as a predictor of kidney disease in diabetics, and was an international authority on diabetes.
Bernard Zinman is a Canadian clinical and research endocrinologist, whose research at the University of Toronto focuses on type 1 and type 2 diabetes. He directed the Mount Sinai Hospital Leadership Sinai Centre for Diabetes and the Banting and Best Diabetes Centre. In 2019, he was appointed as an Officer to the Order of Canada in recognition of his scientific contributions, including the development of preventative therapies for diabetes.
Brian M. Frier is a Scottish physician, diabetologist, clinical scientist, and an Honorary Professor of Diabetes at the University of Edinburgh. He is best known for his many scientific contributions to the pathophysiological understanding of hypoglycemia, a common adverse effect of insulin therapy in diabetic patients whose societal impact has deserved increasing media attention worldwide. His honors include the R.D. Lawrence Lecture of the British Diabetic Association in 1986, the Banting Memorial Lecture at Diabetes UK in 2009, the Camillo Golgi Prize and lecture at the 53rd annual EASD conference in 2017, and the Michael Somogyi Award from the Hungarian Diabetes Association in 2004. Frier is a science book author and editor, and a science journal Chief editor. He is also regarded as an authority on the field of driving and diabetes. In 2023, Frier was accorded Honorary Life Membership by the European Association of Diabetes.
Elizabeth "Beth" Mayer-Davis is an American nutritionist who is the Cary C. Boshamer Distinguished Professor at the UNC Gillings School of Global Public Health. She is the Director of the University of North Carolina at Chapel Hill Nutrition Obesity Research Center, and Dean of the UNC Graduate School. She has sought to better understand diabetes. She was awarded the 2019 American Diabetes Association Kelly West Award.
References
- 1 2 3 Gregg EW (October 2017). "The Changing Tides of the Type 2 Diabetes Epidemic-Smooth Sailing or Troubled Waters Ahead? Kelly West Award Lecture 2016". Diabetes Care. 40 (10): 1289–1297. doi: 10.2337/dci16-0055 . PMID 28798086.
- 1 2 Dabelea D (February 2018). "Diabetes in Youth-Looking Backwards to Inform the Future: Kelly West Award Lecture 2017". Diabetes Care. 41 (2): 233–240. doi:10.2337/dci17-0031. PMC 5780050 . PMID 29358467.
- 1 2 3 "1986 - 2021 Kelly West Award for Outstanding Achievement in Epidemiology | American Diabetes Association". professional.diabetes.org. Retrieved 2023-05-07.
- ↑ "The 2019 Kelly West Award to Be Presented to Elizabeth J. Mayer-Davis, PhD". Medical Device News Magazine. Retrieved 2019-06-03.
- ↑ Cowie CC (June 2019). "Diabetes Diagnosis and Control: Missed Opportunities to Improve Health : The 2018 Kelly West Award Lecture". Diabetes Care. 42 (6): 994–1004. doi:10.2337/dci18-0047. PMC 6609950 . PMID 31110117.
- ↑ Narayan KM (May 2016). "Type 2 Diabetes: Why We Are Winning the Battle but Losing the War? 2015 Kelly West Award Lecture". Diabetes Care. 39 (5): 653–63. doi:10.2337/dc16-0205. PMC 4839169 . PMID 27208372.
- ↑ Meigs JB (August 2010). "Epidemiology of type 2 diabetes and cardiovascular disease: translation from population to prevention: the Kelly West award lecture 2009". Diabetes Care. 33 (8): 1865–71. doi:10.2337/dc10-0641. PMC 2909080 . PMID 20668155.
- ↑ Laakso M (February 2010). "Cardiovascular disease in type 2 diabetes from population to man to mechanisms: the Kelly West Award Lecture 2008". Diabetes Care. 33 (2): 442–9. doi:10.2337/dc09-0749. PMC 2809299 . PMID 20103560.
- ↑ Herman WH (July 2007). "Diabetes epidemiology: guiding clinical and public health practice: the Kelly West Award Lecture, 2006". Diabetes Care. 30 (7): 1912–9. doi: 10.2337/dc07-9924 . PMID 17496237.
- ↑ Wages SN (May 1994). "Klein honored with Kelly M. West Award". Diabetes. 43 (5): 735. PMID 8168654.
- ↑ Adler AI (September 2015). "Trevor Orchard: Fruitful Contributions to Diabetes Epidemiology". Diabetes Care. 38 (9): 1634–7. doi: 10.2337/dc15-0159 . PMID 26294773.